CORCEPT THERAPEUTICS INC — Director's Dealing 2012

Oct 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-10-10

Reporting Person: BRADBURY DANIEL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-10	Stock option (right to buy)	$2.70	A	70000	Acquired	2022-10-10	Common stock (70000)	Direct

Footnotes

F1: Exercisable on the first annual anniversary of 10/10/2012 with respect to 25% of the total number of option shares, and with respect to an additional 2.08334% of the total number of option shares on each monthly anniversary thereafter.